Piedra v. Dugan

21 Cal. Rptr. 3d 36, 123 Cal. App. 4th 1483, 2004 Cal. Daily Op. Serv. 10171, 2004 Cal. App. LEXIS 1900
CourtCalifornia Court of Appeal
DecidedNovember 12, 2004
DocketG032653
StatusPublished
Cited by61 cases

This text of 21 Cal. Rptr. 3d 36 (Piedra v. Dugan) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Piedra v. Dugan, 21 Cal. Rptr. 3d 36, 123 Cal. App. 4th 1483, 2004 Cal. Daily Op. Serv. 10171, 2004 Cal. App. LEXIS 1900 (Cal. Ct. App. 2004).

Opinion

Opinion

FYBEL, J.

Introduction

Rey Piedra, an infant, suffered cardiac arrest, resulting in severe brain damage. Rey’s parents, Jesus Piedra and Agripina Arroyo, as Rey’s guardians ad litem, sued Rey’s treating physician, Dr. J. M. Dugan, for medical malpractice, negligent failure to obtain informed consent, and battery. The trial court granted a motion for nonsuit on the battery claim, and the jury found in favor of Dr. Dugan on the malpractice and informed consent claims.

We conclude the trial court did not err by granting the nonsuit motion on the battery claim. Dr. Dugan was unaware of any condition on the parents’ consent to treatment. Therefore, we hold the physician could not be hable for *1486 battery because he did not intentionally violate the condition on the consent while treating plaintiff. Given the jury’s verdict on the claim for lack of informed consent, even if the court erred in granting the nonsuit, any such error was harmless.

We also conclude there was substantial evidence to support the jury’s verdict on the claim for lack of informed consent; the trial court did not err in instructing the jury regarding the settlement between plaintiff and the other defendants; and the trial court did not err by submitting to the jury the issue of the gross amount of future damages, rather than the present value of those damages. Therefore, we affirm.

Statement of Facts

On April 21, 1994, six-month-old Rey Piedra was admitted to Fountain Valley Regional Hospital and Medical Center (Fountain Valley) with a suspected seizure disorder. Upon his discharge from the hospital on April 25, Rey’s treatment was phenobarbital twice a day to prevent seizures. Rey developed a rash over his entire body, swelling, and a swollen abdomen, and eventually stopped eating. Rey’s mother cut the phenobarbital dose in half, and then stopped giving Rey any medications on May 17.

Rey was readmitted to Fountain Valley on May 20. The on-call physician ordered that phenobarbital be discontinued and replaced with another anticon-vulsant, Ativan, as needed for seizures lasting longer than two minutes.

At Fountain Valley, Rey’s mother signed a form regarding the conditions of admission, in which she consented to “the procedures which may be performed during this hospitalization . . . , including emergency treatment or services, and which may include, but are not limited to laboratory procedures, x-ray examination, medical or surgical treatment or procedures, anesthesia, or hospital services rendered [Rey] under the general and special instructions of [Rey]’s physician or surgeon.” Rey’s mother testified she told the admitting person, two nurses, and Rey’s attending physician, Dr. Magdalena Salcedo, not to give Rey any medication without her knowledge. 1

*1487 Early the next morning, Rey was transferred to the PICU. The initial diagnosis was a drug reaction or “acute systemic reaction to medication.” Dr. Dugan first saw Rey on the morning of May 21. Rey’s liver was enlarged; he was dehydrated, anemic, and suffering from a rash; and he had had an allergic reaction to phenobarbital.

Rey needed fluids and blood products, which had to be administered through a central line. Dr. Salcedo explained to Rey’s parents, in Spanish, that Rey needed a transfusion, and Rey’s father consented in writing to the central line placement. Dr. Salcedo did not, however, discuss with Rey’s parents the medications that would be used to sedate Rey during the placement of the central line. Dr. Dugan believed the consent to the central line procedure included consent to the use of the sedatives.

The placement of the central line began at 10:15 a.m., and was not completed until 3:00 p.m. Rey received two doses of Versed and four doses of ketamine before and during the course of the procedure. Those amounts of the drugs were not unusually large for this procedure in a seven-month-old child. Rey’s mother was never told Rey would be given Ativan, Versed, or ketamine, or what effect those drugs might have on Rey.

Dr. Dugan ordered an echocardiogram to determine whether Rey had any cardiac abnormalities. Dr. Dugan also ordered that Ativan be administered as necessary to calm Rey during the echocardiogram, which was performed at 5:30 p.m. on May 21. A nurse administered Ativan when Rey’s movements were too erratic to allow an accurate echocardiogram.

At 8:35 p.m. on May 21, Rey suffered a prolonged seizure. Dr. Dugan concluded Rey needed emergency treatment and ordered a dose of Ativan to prevent another seizure. Dr. Dugan hoped preventing further seizures would avoid the need to intubate Rey. A PICU nurse testified this dose of Ativan was administered to Rey “in response to emergency situations.” Dr. Dugan acknowledged he did not obtain consent from Rey’s parents for treatment or prevention of seizures with Ativan.

*1488 The results of the laboratory tests, returned at 11:00 p.m., showed respiratory failure and respiratory acidosis (an increased acidity of the blood stream resulting from the inability to eliminate carbon dioxide from the body). Dr. Dugan therefore ordered an immediate dose of Mazicon to reverse the effects of Ativan (which can cause respiratory depression), and later intubated Rey. To prevent movement and reduce pain during the intubation process, Dr. Dugan gave Rey succinylcholine, Pavulon and fentanyl. Rey’s parents’ consent was not obtained for the intubation because it was performed due to a life-threatening emergency.

Around midnight, Rey’s condition began to deteriorate rapidly, and he suffered a cardiac arrest. Dr. Dugan opined Rey’s cardiac arrest was caused by hyperkalemia (a high potassium level), which is a rare adverse effect of succinylcholine. Plaintiff’s expert agreed with Dr. Dugan’s opinion.

Rey continued to suffer subclinical seizures, and was transferred to the University of California at Los Angeles Medical Center because Fountain Valley did not have the capability to monitor his continued seizure activity. As a result of his cardiac arrest, Rey suffered severe brain damage and is likely to remain in a vegetative state for the rest of his life.

A pharmacological expert and a pediatric neurological expert offered by plaintiff testified Rey’s respiratory depression and respiratory failure were caused by the combined effects of phenobarbital, Versed, ketamine and Ativan. Plaintiff’s pediatric neurological expert testified Rey probably did not suffer a seizure on the evening of May 21, but instead he had an episode of respiratory depression caused by the substantial amount of antiseizure or anticonvulsant medications in his system.

A witness, expert in anesthesiology and pediatric critical care, offered by Dr. Dugan, testified Ativan, ketamine, and Versed are commonly used drugs with low risk of harm. The expert further testified the conditions of admission form signed by Rey’s mother upon Rey’s admission to Fountain Valley was a general consent to give such medications. Plaintiff’s expert in pediatric critical care testified the standard of care did not require written consent for the administration of ketamine, Versed, or Ativan.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Parks v. McDonald CA2/2
California Court of Appeal, 2025
Williams Scotsman v. Gagliardi CA4/1
California Court of Appeal, 2024
Ramirez v. County of San Diego
S.D. California, 2024
Stelmach v. Plastipak Packaging CA5
California Court of Appeal, 2024
Singleton v. County of San Bernardino CA4/3
California Court of Appeal, 2024
Johnson v. United States
N.D. California, 2024
Russell v. Walsh CA1/4
California Court of Appeal, 2023
D-Rock Technology v. Sweeney CA1/1
California Court of Appeal, 2022
Caruso v. Gordon Tullett Logistics CA3
California Court of Appeal, 2022
Richmond v. Patel CA2/2
California Court of Appeal, 2021
Jogani v. Jogani CA2/3
California Court of Appeal, 2021
Harmon v. DiRubio CA4/3
California Court of Appeal, 2021
Mann v. Spark Public Relations, LLC CA1/1
California Court of Appeal, 2021
Gierut v. Applied Medical Resources Corp. CA4/3
California Court of Appeal, 2021
Nagel v. Westen
California Court of Appeal, 2021
McAlpine v. Norman
California Court of Appeal, 2020
Farmers & Merchants Trust Co. v. Vanetik
California Court of Appeal, 2019

Cite This Page — Counsel Stack

Bluebook (online)
21 Cal. Rptr. 3d 36, 123 Cal. App. 4th 1483, 2004 Cal. Daily Op. Serv. 10171, 2004 Cal. App. LEXIS 1900, Counsel Stack Legal Research, https://law.counselstack.com/opinion/piedra-v-dugan-calctapp-2004.